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Abstract
Background: Asthma is a prevalent and costly disease resulting in reduced quality of life for a large proportion
of individuals. Effective patient self-management is critical for improving health outcomes. However, key
aspects of self-management such as self-monitoring of behaviours and symptoms, coupled with regular
feedback from the health care team, are rarely addressed or integrated into ongoing care. Health information
technology (HIT) provides unique opportunities to facilitate this by providing a means for two way
communication and exchange of information between the patient and care team, and access to their health
information, presented in personalized ways that can alert them when there is a need for action. The objective
of this study is to evaluate the acceptability and efficacy of using a web-based self-management system, My
Asthma Portal (MAP), linked to a case-management system on asthma control, and asthma health-related
quality of life.
Methods: The trial is a parallel multi-centered 2-arm pilot randomized controlled trial. Participants are randomly
assigned to one of two conditions: a) MAP and usual care; or b) usual care alone. Individuals will be included if
they are between 18 and 70, have a confirmed asthma diagnosis, and their asthma is classified as not well
controlled by their physician. Asthma control will be evaluated by calculating the amount of fast acting beta
agonists recorded as dispensed in the provincial drug database, and asthma quality of life using the Mini Asthma
Related Quality of Life Questionnaire. Power calculations indicated a needed total sample size of 80 subjects. Data
are collected at baseline, 3, 6, and 9 months post randomization. Recruitment started in March 2010 and the
inclusion of patients in the trial in June 2010.
Discussion: Self-management support from the care team is critical for improving chronic disease outcomes.
Given the high volume of patients and time constraints during clinical visits, primary care physicians have limited
time to teach and reinforce use of proven self-management strategies. HIT has the potential to provide clinicians
and a large number of patients with tools to support health behaviour change.
Trial Registration: Current Controlled Trials ISRCTN34326236.
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Asthma is a prevalent and costly disease with expendi-
tures in the US alone of $648 million annually [1].
Despite the availability of effective therapies, optimal
management of asthma remains problematic [2-8].
Much of the cost of asthma care is attributable to poor
disease control due to non-adherence to prophylactic
therapies, inadequate monitoring of disease severity, and
insufficient patient education for effective self-manage-
ment [1].
Effective management requires a strong collaborative
partnership between patients and their care team.
Asthma programs that incorporate strategies to optimise
self-management reduce ED visits [9,10], hospitalisations
[9,11], and healthcare costs [12,13]. However, barriers to
building effective partnerships between patients and the
care team include lack of patient time and engagement,
reduced continuity of care, limited patient self-monitor-
ing of symptoms, and minimal follow-up between visits
by the care team [14-16].
Health information technologies (HIT) can offer novel
opportunities to enhance patient self-management and
patient-provider partnerships by facilitating: 1) active
disease monitoring and feedback with the care team
[17-19]; 2) patient education about successful adoption
and maintenance of health behaviours between clinical
encounters; 3) case management when problems are
identified; and 3) an opportunity to share clinical infor-
mation and treatment goals through patient access to
their personal health record (PHR). Ongoing efforts to
develop, implement, and evaluate computerized-assisted
decision-support and clinical information systems for
clinicians have shown promise in reducing medication
errors and healthcare utilisation [20-43]. Limited work,
however, has been completed in the area of decision
and self-management support systems for patients [42].
The Chronic Care Model and Patient Self-Management
Support
The Chronic Care Model (CCM) [44] is an evidence-
based, client-centered framework to improve care for
individuals with chronic disease and provide support for
their caregivers. A basic tenet of the CCM is that pro-
ductive, patient-centered interactions between informed
patients and knowledgeable teams across the care conti-
nuum can lead to optimal outcomes. The CCM compo-
nent with the second strongest evidence base is patient
self-management support, [45] which empowers indivi-
duals to develop the self-efficacy and skills needed to
manage their health effectively.
Engaging and training patients to manage their asthma
Self-management is the individual’s ability to manage
the symptoms, treatment, physical, and psychosocial
consequences and lifestyle changes inherent to living
with a chronic health condition [46]. Beyond providing
education and supportive counselling, self-management
programs also teach specific skills with proven effective-
ness [10,16,47,48]. The impact of self-management on
health outcomes is thought to occur primarily through
changes in health behaviours by providing patients with
the confidence to engage in tasks and to acquire core
knowledge and skills aimed at helping them better man-
age their health [16,49].
Optimal long-term management requires ongoing
monitoring of asthma control by patients, coupled with
an individualized written asthma action plan. This
allows patients to quickly identify and address subopti-
mal disease control by adjusting medications or by con-
tacting their physician [50-52].
Many individuals with asthma lack the necessary
k n o w l e d g et oe f f e c t i v e l ym a n a g et h e i ra s t h m as u c ha s
how to avoid common triggers and the role of medica-
tions in preventing and addressing worsening symptoms
[16,53]. Often, patients do not recognize early signs of
exacerbations [54,55]. It is estimated that less than 40%
of patients regularly monitor their symptoms [56] and
even fewer initiate their prescribed action plan at the
first signs of an exacerbation [57,58]. As a result, even
when an action plan is available, only a minority of
patients titrate their therapy as directed [57,58]. In turn,
the exacerbation may escalate to the point of requiring
urgent medical attention with an increased risk of mor-
bidity and mortality [59].
A number of studies have also found that many indivi-
duals with asthma have suboptimal levels of physical
activity and aerobic endurance [60-63]. However, there
has been relatively limited interest and success develop-
ing interventions to improve physical activity in asthma
patients [64,65]. Reinforcement and follow-up are key
predictors of long-term adherence to increased physical
activity [65,66]. Support from others (e.g. health profes-
sional, peer group, trainer) can improve self-efficacy and
adherence [67,68]. Proven strategies that facilitate the
adoption and maintenance of increased physical activity
levels include setting realistic goals, tailoring activities
based on enjoyment and personal history, identifying
and addressing common barriers such as time con-
straints, and monitoring progress [69,70].
The episodic nature of asthma symptoms and exacer-
bations may be a significant barrier to effective self-
management. Decision research on trend perception has
shown that it is difficult to recognize changes in trend
in disease control when information on momentary
experiences is presented in a partitioned manner
[71,72]. In the context of asthma, if patients view their
disease as a series of acute episodes, this impairs their
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vious studies using simple alert systems have had little
effect in improving asthma control [58], graphically
representing changes in asthma control over time may
increase the salience of this information. HIT tools that
can improve trend perception combined with feedback
f r o mt h ec a r et e a mh a v et h ep o t e n t i a lt oi m p r o v es e l f -
management. Web-based technology allows real time
visual representation of asthma control over time [17].
Studies have also found that when patients have
greater asthma knowledge of how to use their action
plan effectively and are given appropriate tools to moni-
tor symptoms and document changes, they are better
able to learn and develop the skills needed to optimise
asthma control [73,74]. These skills centre on problem
solving when symptoms worsen, decision making to
identify optimal actions (e.g., increase medicines or call
the care team), and the ability to find and utilize
resources [53]. Finally, given the wealth of available
health information, sorting through what is relevant and
appropriate is another skill that individuals need to mas-
ter [16,53]. When information is easily accessible at the
time it is needed (e.g., when symptoms worsen), patients
a r em o r el i k e l yt ob ea b l et oa c to nt h ei n f o r m a t i o n .
The ability to access the appropriate information, tai-
lored to their needs and preferences, and coupled with
the knowledge that they have ongoing support and feed-
back from the care team, can enhance confidence to
develop the necessary skills to engage in essential self-
management tasks.
Ongoing Monitoring and feedback from the care team
Another important contributor to suboptimal manage-
ment of asthma is the lack of follow-up by the care
team between visits [16,75]. Efforts to persist in ongoing
self-monitoring and self-management are often directly
related to the extent to which patients perceive that
they have access to and receive feedback from the care
team [75-77]. Many patients have difficulty recognizing
early signs of deterioration and do not access their care
team in a timely manner [78,79]. Given the high volume
of patients, primary care physicians often have limited
time for regular monitoring, feedback, and reinforce-
ment. Even when face-to-face asthma education pro-
grams are available, many patients are not able to attend
and often these programs do not incorporate necessary
self-management skill training [80-83].
Reminders to monitor their asthma and share results
with the care team have been shown to improve medi-
cation adherence [84]. Such approaches allow patients
to partner with their care providers, routinely discuss
trends and rhythm of their disease and share in deci-
sion-making [85]. Patients engaged in their own care
may be effective catalysts for changing and optimizing
clinical management of their asthma.
Chronic disease case-management can effectively
improve symptoms and health-related quality of life of
patients with chronic obstructive pulmonary disease,
diabetes, and coronary heart disease [86]. Case managers
play a critical role engaging patients in treatment and
providing ongoing monitoring and feedback with the
clinical team [87]. To achieve this, case mangers require
real time access to patients’ medical records and patient
reported outcomes and other information that will aid
in the identification of problems as they arise. These
two key principles, engaging and training patients to
manage their asthma and providing patients with active
monitoring and feedback from the care team, were used
to develop My Asthma Portal (MAP) (Figure 1) and the
linked nurse case-management system.
Objectives
The objective of this study is to evaluate the acceptability
and test the efficacy of using MAP linked to a case-man-
agement system on asthma control, and on asthma health-
related quality of life. We hypothesize that higher rates of
usage of MAP will be associated with greater improve-
ments in asthma control and asthma-related quality of life.
Design
The study is a parallel multi-centered 2-arm pilot ran-
domized controlled trial (controlled-trials.com identifier
ISRCTN34326236). Participants are randomly assigned
to one of two conditions: a) MAP and usual care; or b)
usual care alone.
Participants
Participants are recruited from pulmonary clinics in two
tertiary care hospitals in Montreal, Canada.
Inclusion criteria
a) Males and females Age 18 to 69 years
b) Physician diagnosis of asthma and prescribed at
least one rescue medication.
c) Classified as having poor asthma control by their
doctor
d) Access to the internet
e) Smoking < 20 pack-years
f) Can speak and understand English or French
Exclusion criteria
a) Diagnosis of COPD
b) Other serious medical diagnoses (e.g. lung cancer).
Interventions
Control Intervention - Usual Care
Patients receive ongoing asthma care from a respirolo-
gist. An asthma nurse provides education and follow-up
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triggers, taking all asthma medications as prescribed,
and using the written action plan as needed. Follow-up
phone calls between visits are provided by the asthma
nurse, when appropriate (i.e. missed appointments, to
clarify aspects of the action plan or prescribed asthma
medications).
MAP linked to a nurse-case management system
Initial set up and information exchange
Three systems are linked together, MAP, the nurse case-
management system, and a light MOXXI electronic
health record (EHR). The EHR contains drug informa-
tion entered by the physician and from the Quebec pro-
vincial health database (RAMQ) including: 1)
medications prescribed by the physician, and the RAMQ
record for all drugs dispensed, medical services pro-
vided, ED visits and hospitalizations. Relevant data from
the EHR are sent to MAP and the nurse case-manage-
ment system. The MAP system also provides links to
selected patient educational materials from credible
online resources.
Participants are given a MAP username and password
and are asked to access the internet from anywhere
(home, work, library). They are asked to select the num-
ber of times they will commit to logging in per week,
with a minimum log in of at least 1×/week. During the
first time log in, they complete a My Profile page to ver-
ify basic demographic information, enter additional
health information (e.g., smoking status, allergies, trig-
gers) and select initial health goals to work on.
Once patients complete the initial log-in, their infor-
mation appears in the nurse case management system.
When the nurse receives a new participant file, she
reviews the accuracy of the medication list, the action
plan details, and clarifies discrepancies with the referring
physician, if needed. As patients complete monitoring
information in the MAP system (symptoms, medication
adherence, action plan use, and physical activity), the
information appears simultaneously in the nurse case-
management system. Based on information from the
EHR and participant responses to patient reported out-
comes in MAP, the MAP and nurse case-management
systems provide clinical decision support (described
later on) to patients and the nurse. The flow of informa-
tion between MAP and the other systems is presented
in Figure 2.
Patient Portal: MAP design and features
MAP was designed to allow patients to: 1) view their per-
sonal health information (asthma medications, other
health problems) 2) view general asthma health informa-
tion through links to specific educational websites (learn-
ing center) and receive new asthma education tailored to
participants gaps in knowledge and clinical information (e.
 
 
 
 
 
 
 
MAP= My Asthma Portal 
MAP 
Tailored education 
Asthma medical information 
Tools to optimize self-management 
Health behaviors 
Nurse case management support 
Increased 
self-efficacy 
 
Increased 
quality of 
life 
Reduced use 
of 
unnecessary 
healthcare 
resources 
Self-
management 
support 
Productive 
interactions 
with the 
care team  
Figure 1 Relationship between MAP and Health Outcomes. MAP = My Asthma Portal.
Ahmed et al. Trials 2011, 12:260
http://www.trialsjournal.com/content/12/1/260
Page 4 of 17g. educational information on the medications they are
taking); and 3) facilitate monitoring and feedback to better
self-manage their asthma (summary of MAP Features,
Table 1). Key principals were used to guide the design of
user-friendly screens and the organization and display of
educational material including Instructional Design (ID)
[88-92], User Centered Design (UCD) [93-95], Informa-
tion Architecture (IA) [96-98], Human Computer Interac-
tion (HCI) [93], health literacy [99-102], and usability
principles [103-106]. These included organizing informa-
tion in a way that would make the system intuitive for
patients to use, visually appealing, and organized to facili-
tate key self-management activities. Colors were chosen
based on their widespread application both within the
medical community and within society [107] and also to
help distinguish information entered by patients from that
entered by the healthcare team. A user-centered iterative
design process [108,109] was used to design the MAP
interface. This process involved 3 nurses, 2 physicians, and
10 patients (5 for focus group, 5 for individual interviews)
attending an asthma clinic (Montreal Chest Institute,
asthma clinic where PE works) who were asked to provide
feedback on the tool and based on the feedback changes
were made to the content and layout of the system. This
process continued until no more changes were suggested.
The Patient Home Page highlights key elements of
MAP and guides patients to areas of interest (Figure 3).
The home page introduces the five core self-manage-
ment areas included on the website.
￿ Update My Asthma Target. Here, patients enter
their monitoring information each time they log in.
DB= database 
MAP= My Asthma Portal 
EHR= Electronic Health Record 
MOXXI = Medical Office of the Twenty-First Century 
Figure 2 Integration of MAP with the MOXXI EHR and nurse case-management system. DB = database. MAP = My Asthma Portal. HER =
Electronic Health Record. MOXXI = Medical Office of the Twenty-First Century.
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(previously entered in the My Profile page and
reviewed by the nurse case manager). Each week,
patients are prompted to complete the series of
questions that assess symptoms, need for urgent
care use (i.e., unscheduled office or ED visit), asthma
medication use (medications are pre-populated in
the system from the EHR), understanding of the
steps of the action plan, action plan use, and physi-
cal activity. During subsequent log-ins each week,
patients are only asked about medication adherence,
action plan use, and physical activity information
after the first login. All other monitoring informa-
tion (symptoms, need for urgent care, understanding
of the action plan) is assessed only once per week.
￿ My Health Profile. After each completion of the
monitoring evaluation, patients are directed to the
My Health Profile to review My Asthma Target (Fig-
ure 4) that summarizes how well they are achieving
targeted goals in the areas monitored (symptom
Figure 3 MAP Home Page.
Table 1 Summary of MAP Features
Care Management Gap MAP Feature
Asthma related knowledge Tailored education by linking educational material to parts of the personal
health record
Learning Center
Knowledge of personal asthma medical information Asthma Personal Health Record
Self- monitoring of asthma symptoms and health MAP tracking system:
Symptoms
Medication adherence
Action Plan Use and Understanding
Physical Activity
Guidance for adopting optimal self-management behaviors:
Adherence to preventative medication, Starting and maintaining
action plan use as prescribed
Initiating and maintaining physical activity
Developing a partnership with the healthcare team
Create short-term behavior-change goals that are realistic, achievable and
sustainable
Decision Support
Visual feedback of monitoring information and health behavior improvement
through My Asthma Target
Ongoing communication and support from the care team Communication and feedback from a nurse case manager
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inhaler, medication adherence, appropriate use of
the action plan, and physical activity) based on the
updated information. This section allows patients to
track asthma behaviours and receive feedback at a
glance. Both color-coding (green, yellow, red) (Figure
4), and text feedback in the ‘Advice From Your
Healthcare Team’ box are used to convey how well
they are reaching targeted goals. Because examining
trends over time may facilitate problem identifica-
tion and promote health behavior change, graphs
that show longitudinal trends over a 6 month period
in symptoms, use of rescue medication, medication
adherence, and number of steps walked (as an indi-
cator of physical activity) are presented. Each graph
also indicates the date on which a participant had a
respiratory-related ED or urgent care visit to help
link participant behaviors with relevant outcomes.
￿ My Medications. Because proper use of medica-
tions is central for optimal asthma control, a sepa-
rate tab was created that lists the name of each
medication, type (controller, rescue), and how it
should be used (i.e., frequency and dose). A separate
tab is also available where patients can view their
color-coded action plan (My Action Plan) (Figure 5).
Given the importance of the environment and avoid-
ing stimuli that trigger exacerbations, the
participant’s asthma triggers are highlighted across
the top of the action plan.
￿ My Mail. To facilitate communication and part-
nership building with the nurse case-manager, a
separate tab was created to allow patients to email
and receive messages from the nurse. The email
view was designed to look similar to other common
email applications in terms of the functions for
creating and sending an email, and folders.
￿ Learning Center. Here, patients can view a table of
contents of links to external sites gathered from
legitimate sources of asthma and health educational
information that were selected by the research and
clinical team. Note: Links to educational materials
are also directly integrated within the main content
of the site to facilitate use. Throughout various parts
of the portal, patients have information links that
redirect them to specific content in the learning cen-
ter thereby tailoring the educational material they
are presented to their personal health information.
For example, each medication has an information
button that will direct the participant to the Quebec
Ministry of Health Drug Database site http://www.
guidesante.gouv.qc.ca which offers a description of
the medication, intended use, side effects, along with
potential interactions with other drugs or health
conditions. Similarly, if patients indicate that they do
Figure 4 My Asthma Health Profile.
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to monitoring questions) they are taken to a web
page that describes an action plan and its impor-
tance for asthma control.
Nurse Case Management System Design and Features
The nurse case-management system was designed to: 1)
Quickly identify patients that may require immediate
care; 2) Collate relevant medical and monitoring infor-
mation for each participant; 3) Document participant
management information, including interactions by
phone and through email, and interventions and advice
provided during interactions.
￿ Participant List: The first view in the nurse case
management portal is a participant triage list color-
coded and ordered by urgency with respect to parti-
cipant control status (i.e. those classified as not hav-
ing good asthma control and not using their action
plan will appear first) (Figure 6). The nurse’sd a s h -
board also includes a summary of alerts related to
asthma monitoring (described below) and sorted by
date.
￿ Participant EHR: Once the nurse clicks on a parti-
cipant in the list, the nurse has access to the partici-
pant’s EHR and information from MAP, including:
physician name and contact information; history of
symptoms and urgent visits; written action plan;
asthma medications listed by the participant, and
medications prescribed and dispensed; patients’
monitoring information (same view as seen by
patients under the My Health Profile:s y m p t o m s ,
need for urgent care (unscheduled visit or ED visit),
daily use of asthma medications currently prescribed,
participant comprehension of the action plan and
action plan use, and physical activity); all email
exchanges between the nurse and participant; clinical
notes section where the nurse documents participant
care and support assessments and interventions;
activity log that shows all previous participant case-
management activities and clinical notes on the
nurse portal ordered by date.
Business Logic Engine for My Asthma Target and Alerts
Patient Alerts The first line of feedback to patients is
generated automatically from the MAP database system
Figure 5 MAP Action Plan.
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participant and information from the EHR system. The
business logic for the color-coding and advice presented
to patients is summarized in Table 2. An alert is sent to
patients via email when the system identifies that a partici-
pant’s asthma is poorly controlled and the participant indi-
cates they have not initiated use of their action plan, if the
nurse has updated the action plan, or if they have not
logged in for 7 days (Table 3). The participant is given an
opportunity to act on these alerts and if the flag of a pro-
blem for any of these areas remains for 48 hours, the alert
status is escalated to notify the nurse case-manager.
Nurse Alerts Upon receiving this notice, the nurse fol-
low-ups with the participant within 24 hours through
the MAP mail system or by telephone. Additional alerts
are sent to the nurse when a new participant is enrolled
and needs to have their action plan reviewed, the parti-
cipant indicates that he/she does not understand his/her
action plan, or there is a change in the way a participant
is taking their medication based on the medication
adherence monitoring assessment (Table 3).
Measurements
Participant Demographics
Demographic information such as participant sex, age,
and indicators of social economic status (e.g. house-
hold income) will be abstracted from baseline
questionnaires.
 
OOC= Out of control 
AP=Action plan 
Figure 6 Nurse Case-Management Triage Patient List. OOC = Out of control. AP = Action plan.
Table 2 Monitoring business rules
Green Yellow Red
Symptoms No symptoms 1 symptom 2 symptoms and/or emergency visit
Overuse of rescue puffer* P < 150 250 > P ≥ 150 P ≥ 250
Adherence to preventative medication# n/d ≥ 90% 90% > n/d > 70% n/d < = 70%
Exercise† number steps ≥ average number steps > 2/3 of average number steps < 2/3 of average
Action Plan Understanding% “Yes” to all questions N/A “No” to at least one question
* (P = number of puffs corresponding to all FABA and combivent dispensed over last 3 months)
# (quantity dispensed/3 months) [144]
† Calculated once exercise monitoring questionnaire is completed 4 or more times (average is the mean value for the first three entries, × = the last steps entry)
%Action Plan questions: do you understand what to do in your action plan?; Are you able to describe the signs or symptoms you have when your asthma is
getting worse?)
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Asthma control will be evaluated by examining overuse
of rescue fast acting bronchodilators (beta2-agonists)
(FABA) (i.e. participants will be classified as overused
yes/no). Excessive use of rescue fast acting bronchodila-
tors was included as an indicator because it is associated
with an increased risk of hospitalization and death from
asthma [110], and is defined as the dispensing of more
than 500 doses of the most commonly prescribed fast
acting beta2-agonist salbutamol 100 mcg, 2 inhalations
at the time, or the equivalent for other fast acting
bronchodilators in the last six months of follow-up.
Doses dispensed will be based on quantities recorded in
dispensed prescriptions from the RAMQ and private
pharmacy prescription files. The maximum acceptable
use of fast acting beta2-agonists is derived from recom-
mendations in the guidelines that allow up to 3 doses
per week and a daily dose for the prevention of exercise
induced symptoms [51]. Previously developed methods
will be used to adjust quantities dispensed for prescrip-
tions filled before and immediately before the end of the
item window for assessment [111].
Asthma Quality of Life
The Mini-Asthma Quality of Life Questionnaire (Mini-
AQLQ) was developed to measure the four functional
impairments that are most important for adults (symp-
toms, emotions, exposure to environmental stimuli and
activity limitation) [112,113]. It has 15-items measured
o na7 - p o i n tL i k e r ts c a l e .T h eM i n iA Q L Qi sw i d e l y
used in asthma clinical trials because it has good inter-
nal consistency (interclass correlation coefficient = 0.83),
and a strong cross-sectional correlation with the 32-
item AQLQ of 0.9), and moderate level correlation of
0.69 (both cross-sectional and longitudinal correlation)
with the Asthma Control Questionnaire [112,114], and
it is sensitive to change (reliability index = 0.97) [112].
Secondary Outcomes
Acceptability and attitudes toward the web portal
The Technology Acceptance Model (TAM) [115-127]
questionnaire will be used to assess acceptability and
attitudes toward the web portal. The instrument was
found to be reliable and valid (convergent, discriminant)
for measurement of perceived ease of use and usefulness
[121,123,128-130]. Reliability coefficients range from
0.92 to 0.98 for perceived usefulness and 0.88 to 0.94
for perceived ease of use [121,128]. Perceived usefulness
and ease of use were significantly correlated with both
self-reported current usage (r = .63, r = .45) and self-
predicted future usage (r = .85, r = .59) in two different
populations (users within IBM Canada’s Toronto Devel-
opment Laboratory, evening MBA students at Boston
University) [129].
Usage rates of the system will also be assessed by
examining automated audit trails (logs), which will
include the frequency of use defined as the number of
Table 3 Alerts to Patients and Nurse Case Manager
Event or trigger Alert to patient Alert to nurse
Patient Not logging into MAP Emails sent at 7 days and 14 days
since the last log-in to the patient.
Alert to nurse at 21 days since the last log-in.
Asthma Out of Control (OOC) and
Action Plan Use
Patient OOC and action plan not
started:
Email to patient within 24 hours of
OOC status detected
Nurse receives alert “AP not started” alert (after 48 hrs)
If patient starts action plan:
Patient turns yellow in case management patient list and stays yellow
for 14 days.
Nurse updates action plan of a
patient:
Email to patient and pop-up when
patient logs-in
Patient indicates not understanding
action plan
Nurse receive alert and contacts patient
Add/change medication:
Patient adds or changes medication
in asthma target questionnaire
Nurse receives “create/review action plan” alert
If it is the patient’s first entry of medication the alert is an “Initial drug
list” alert
Preventative medication monitoring Increase or decrease of intake triggers alert to nurse
Rescue medication monitoring:
FABA, oral corticosteroid
Increase triggers alert to nurse
Discrepancy in medication detected:
Discrepancy between what is
prescribed and what is dispensed
After 1 week an email is sent to the
patient
After 2 weeks an alert is sent to the nurse
Change in medication detected:
Physician enters change through
MOXXI for patient’s asthma
medication
If, when the patient fills out the monitoring questionnaire, patient
does not update medication change, an alert is sent to the nurse
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Patterns of usage will include the number of days/week
and times that patients logged in, and which features of
the system they used including number of messages
sent to the asthma nurse. Additional open-ended ques-
tions will be asked to receive further feedback about the
usefulness of the system and how it fits with individuals’
self-management practices.
T h eC h r o n i cD i s e a s eS e l f - E f f i c a c yS c a l e[131], has
been shown to have adequate psychometric properties
in patients with chronic arthritis and several conditions
including hypertension, diabetes, congestive heart fail-
ure, recent myocardial infarction, major depression,
and/or depressive symptoms [132] and was adapted to
assess asthma self-efficacy. The test-retest and the inter-
nal consistency reliabilities were respectively 0.77 and
0.97 in an asthma patient population [133]. In the
chronic arthritis population, items for test-retest reliabil-
ities ranged from 0.71 to 0.85; all the correlations for
construct and concurrent validity were significantly dif-
ferent from zero (p < 0.01): r = -0.35 to -0.68 for base-
line self-efficacy with baseline health status, r = -0.32 to
-0.68 for baseline self-efficacy with 4-month health sta-
tus, r = -0.48 to -0.73 for 4-month self-efficacy with 4-
month health status; r = 0.61 for concurrent validity
(perceived performance and actual performance) [131].
Patients rate their level of confidence, 1 = not confident
at all, 10 = very confident. Level of confidence will be
rated with respect to: taking medications as prescribed;
items that are behaviour-specific related to recognition
and appropriate management of deteriorating asthma
symptoms including ability to identify signs of deteriora-
tion and need to initiate the prescribed action plan;
capacity to keep a healthy diet; ability to do exercise or
physical activity on a regular basis.
Medication Adherence
Adherence to controller asthma medications will be
evaluated by comparing medications prescribed to medi-
cations dispensed based on the prescription claims in
the RAMQ system. This will be calculated using vali-
dated methods we developed to adjust quantities dis-
pensed for prescriptions filled before and immediately
before the end of the time window for assessment [111].
Health care Utilization
Asthma-related ED visits or hospitalizations will be
abstracted from provincial database (RAMQ) using vali-
dated algorithms [134] which lists information on the
date, type, provider, and location of service delivery (e.g.
inpatient, emergency, clinic) for all medical services
remunerated on a fee-for-service basis (approximately
86% of all services) [135].
Resource Utilization: “I n f o r m a t i o no nt h et i m es p e n t
by the nurse case manager (type of call, who is making
the call, duration and reason) will be recorded, and will
allow us to address health service research issues and
knowledge translation to other practitioners and health
care organizations. All health-care resources used during
the 6-month follow-up will be considered. Intervention
costs will include resources used to develop the web-
based tool, train patients and nurses to use the system,
administer the intervention (time spent for research
data collection will not be included). Real time spent
with each patient will be carefully documented by each
study case manager. Case manager salary costs will be
estimated based on the average pay scale of the Federa-
tion of Nurses of Quebec. Physician fees will be based
on those set by the Provincial Health Insurance Board
[136]. “Healthcare utilisation": Information from the
provincial health insurance program administrator,
RAMQ, will be obtained on asthma-related ER visits or
hospitalizations. Total cost per ED visit will be based on
data from earlier studies conducted in the province of
Quebec [137,138]. ED visit will be a separate resource
item from hospitalization. Hospitalization costs will be
based on a Quebec index called the Niveau d’Intensité
Relatif des Ressources Utilisées (NIRRU)” [139].
Sample Size
The primary outcome for this study is change in
asthma control. We hypothesized that use of MAP
would be associated with a 10% reduction in the pro-
portion of patients classified as being in poor control.
Based on MOXXI-II results, we have estimated that
19% of asthma patients will either be seen in the ED
for respiratory-related problems, or use greater than
500 doses of fast-acting beta2-agonists in a 6-month
period. Thus the intervention would need to reduce
the proportion of asthmatics in poor control to 9% to
be considered to be sufficiently effective for policy and
practice adoption.
Thus, to detect a 10% difference in proportions, [140]
with 80% power using a cutoff for statistical significance
of 0.05, the sample size needed is 67 participants in
total. To account for attrition and loss to follow-up, we
will recruit an additional 13 subjects for a total of 80
participants, and 40 participants per arm [141].
This sample size will also allow us to detect a minimal
important difference of .5 on the AQLQ [113,142],
using the Mini-AQLQ a difference as large as 0.97 (SD
.61) was found to be clinically meaningful and signifi-
cant [114,143-145].
Recruitment
Potential participants are informed about the trial by
their respirologist or the nursing staff. For individuals
who agree to participate, the research coordinator
further describes the study, responds to questions, and
obtains informed and written consent.
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Randomization
Treatment allocation is done by random permutation
within blocks with block sizes of 4 and 6. Randomiza-
tion is stratified by center. The randomization is done
independently of centres, coordinator, and clinical staff.
The randomization is performed with a randomization
algorithm developed as part of the McGill University
clinical and health informatics research tool kit. The
relevant information is only accessible to an employee
of McGill University Health Center who is not involved
in the trial. After the inclusion of a participant in the
trial and the baseline assessment, the study coordinator
receives information concerning the allocation of
patients to the intervention or control arm by sequen-
tially generated logs through the study coordinator
online system. Therefore, the fidelity of allocation is
guaranteed.
Statistical methods
Descriptive statistics will be used to evaluate differences in
the baseline characteristics of participating patients in the
two arms of the trial. Study hypotheses will be tested
using an intention-to-treat analysis, whereby all consenting
patients who were randomized during the accrual period
will be included in the analysis. Analysis of the primary
outcome, the proportion in each group that are in control
and out of control based on doses of fast-acting beta2-ago-
nists, will be compared using a chi-square test. Changes
on the Mini-Asthma Quality of Life Questionnaire
(AQLQ) will be compared by independent sample t -tests,
and differences between mean change scores will be
expressed with 95% confidence intervals (CIs). To deal
with missing data we will conduct a sensitivity analysis
using multiple imputation [146,147] to explore the effects
of missing data on the results. Changes in other secondary
outcomes, including COPD HRQL, will be evaluated using
t-tests for continuous variables and chi-square for catego-
rical variables [141], such as individual items on the TAM
that asked about perceived benefit of features of the sys-
tem and intention to use the system. While our sample
size will limit our ability to conduct extensive multivariate
analyses, we will assess which characteristics are associated
with changes in the primary outcome using multivariate
regression analyses with selecting variables in each model
and adjusting for potential effect modifiers, (e.g. self-effi-
cacy, adherence, age, sex).
Study Timeline
Recruitment started in March 2010 and the inclusion of
patients in the trial in June 2010. Follow-up evaluations
are conducted at 3 months, 6 months, and 9 months
after randomization.
Description of Risk
The risks to patients are judged to be minimal as the
intent is to facilitate the implementation of evidence-
based self-management where the benefits have already
been shown to outweigh the risks of treatment
[12,13,29,39,113,148], and system-generated advice to
patients is monitored by an asthma nurse. A three phase
quality assurance process is used to detect bugs whereby
a study respirologist (PE) reviews the recommendations
generated to ensure their appropriateness and suggests
changes to the software if needed.
Ethics Principals
The study is being conducted in accordance with Medi-
cal Research Council Ethics Guidelines. Study participa-
tion is entirely voluntary and participants are advised
they can withdraw from the study at any time without
provision of reasons and without negative consequences
for their current or future medical care. Ethical approval
and scientific review for this study was obtained from
the McGill University Health Center (IRB review num-
ber A10-E36-08B).
Informed Consent
Prior to study participation patients receive written and
oral information about the study process and required
time commitment. Potential benefits (mainly to society)
and risks are explained in detail. All individuals who
wish to be a participant must sign the MUHC approved
consent form. In case of study discontinuation the parti-
cipant will be asked whether they agree to allow all
information collected up to the time of withdrawal to be
used.
Data security/disclosure of original documents
Information collected during the study will be kept in
secured offices. Information collected will only be used
for the purpose of answering the research objectives of
this study. Information provided to fulfill study require-
ments is not accessible to the nurses and physicians at
the recruiting centers. Completed study questionnaires
are mailed directly to the coordinating study office by
the participants. As per Ethics Review Board regulations,
data will be kept for 7 years after termination of the
study.
All study related data and documents are stored in a
protected central server of McGill University, and paper
versions locked in filing cabinets in the McGill offices of
the principal investigator (SA). Only investigators and
staff associated with this study can access the respective
files. Intermediate and final reports are stored in the
McGill University office of the principal investigator.
Discussion
Asthma represents the largest segment of respiratory
diseases among Canadians with an associated cost of
$306 million per year. When it comes to asthma,
ongoing team care and follow-up is often limited and
fragmented [149], and case- management is typically
available only in specialized centers. Health information
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asthma management by providing a means for two way
communication and exchange of information between
the patient and care team. MAP provides patients with
timely access to their health information coupled with
case-management, presented in personalized ways that
can alert them when there is a need for action, and may
empower them to self-manage more effectively and
facilitate and reinforce health behaviour change.
The main focus of this trial will be on evaluating the
benefit of MAP on asthma control and health-related
quality of life. The increasing importance of multidisci-
plinary care in chronic disease gives reason for the
implementation of the case manager who can assume
the role of a coordinator and act as an interface between
the different disciplines. One of the concerns is the
increased demand on case manger time outside of the
clinical encounter. We have designed the case manager
system in a way to minimize needed time on the nurse’s
part and to facilitate access to information. Future work
will examine the cost implications of providing nurse
case management via information technologies through
a patient portal compared to traditional care approaches.
Another potential challenge may be identifying the
training needed of individuals who will use the system.
While some patients are more intuitively inclined to
learn how to use new technologies, some require more
training time and support than others. This will be
monitored through the trial to identify participant pro-
files that will inform future design of systems like MAP
and to streamline the training process.
With any web-based tool a further concern is the dif-
ferential access and comfort of participants with tech-
nologies in general for older, poorer, and less educated
people who are less likely to adopt the web-based sys-
tem described here [150]. The implications are that we
may recruit younger and more educated individuals who
are more inclined to have access to computers and thus
the results may not be immediately generalizable to
other patient groups. Further, MAP is a multi-faceted
intervention and the results from this trial will not be
able to attribute any potential improvement in outcome
to a specific component of the intervention. If benefits
are found from this pilot, future studies will incorporate
comparison groups to identify specific components of
MAP that are necessary for improving outcomes.
As new technologies are developed and their benefits
rigorously evaluated, the provider-patient workflow will
continue to evolve. The challenge remains to develop
integrated systems of care that permit easy access to
information, enhance collaboration between clinicians
and patients, and emphasize a patient-centered approach
to care by addressing the self-management needs that
are most relevant to patients. Individual access to
patient health portals coupled with self-management
tools and efficient feedback from the care team repre-
sents one such new paradigm of care. Results from our
study will provide clinical trial evidence for the clinical
impact of a web-based chronic disease management sys-
tem and a new structure for collaborative care.
Trial status
Ongoing
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